PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
14. Bates 2004 University B -0.4 -0.2 0.0 0.2 Mean Z score Clear goals Openess Independence Good teaching workload Assesment High didactic Low didactic Lectures, exams, timetable University A University C
19. Syllabus – the Knowledge problem … pharmacy syllabus is overcrowded chemistry pharmacology biotechnology genetics medicine analysis formulation physical chemistry ethics pharmacognosy phytochemistry drug design immunology pharmacokinetics therapeutics pathology epidemiology health economics chemical analysis physiology proteomics statistics law Licensing&marketing ADRs microbiology medicinal chemistry biochemistry toxicology drug metabolism genomics social & behavioural sciences
20.
21.
22. 10% 20% 30% 40% 50% 60% 70% 1996/97 1997/98 1998/99 2001/02 Pharm Care Competence (OSCE) 60% 30% McRobbie et al Graduation One year later
23. “ Competence” is a complex educational construct… ...with new currency value Skills Behaviours Knowledge Values attitudes Competency Skills Behaviours Knowledge Values attitudes Competency Skills Behaviours Knowledge Values attitudes Competency Skills Behaviours Knowledge Values attitudes Competency
24.
25. Miller’s pyramid Does Shows how Knows how Knows From UG to post-registration development performance assessment in vivo performance assessment in vitro clinical context assessment factual assessment Practice-based, MiniPAT, MiniCEX, etc OSCE style Case studies/ PBL /Portfolio MCQ / Exams
26. Predominantly FDL and e-modes Predominantly face-to-face modes Cohort learners Lone learner On-site (HEI) learning Off-site (work) learning Learning modality with time/career pathway FDL, e-modes off-site, experiential Independent Career driven UG UG/Pre Post-reg Higher
27. Pharmacist Development Strategy Consultant pharmacist Higher level practitioners eg. PhwSI General practitioner Competency progression Development Contributing knowledge & skills Acquiring Knowledge & skills Research & teaching PhD/MPhil New D level MRes PG M level Diploma Registered pharmacist
28.
29. Logrank P = 0.0048 Intervention = GLF n = 30 hospitals Time - months 14 12 10 8 6 4 2 0 -2 Probability .7 .6 .5 .4 .3 .2 .1 0.0 -.1 Intervention Testing general level competency framework in junior pharmacists Non-intervention
30. -2 -1 0 1 2 -2 0 2 4 6 F E M F E M F E M F E M F E M HOMALS Quantification Higher level practitioners n = 390 Expert PP Leadership Management E & T R & E Practice level Specialist in training Experienced practitioner Leading-edge practitioner
31.
32.
33.
34.
35. What will high-income countries be suffering from in 2030? (Source: WHO) Depression Heart attack Dementia Alcohol Diabetes Stroke Hearing loss Lung cancer Osteoarthritis Emphysema Percentage of total illness
36. What will low income countries be suffering from in 2030? (Source: WHO) AIDS Birth Depression Road accidents Heart attack Pneumonia Diarrhoea Stroke Cataracts Malaria Percentage of total illness
37.
38.
39.
40. Pharmacy Education: Do we have a choice? Professor Ian Bates The School of Pharmacy University of London